Home / NYT / Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

Transplant Patients Need Anti-Rejection Drugs. Why Won’t Insurers Pay for Some of Them?

00:08 NYT

By GINA KOLATA from NYT Health https://ift.tt/2CQNI7l

No comments

Subscribe to: Post Comments ( Atom )